TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Nordic Executive Medicine AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
3,326
|
3,214 | |
| Financial expenses |
7
|
10 | |
| Earnings before taxes |
34
|
303 | |
| EBITDA |
41
|
313 | |
| Total assets |
475
|
396 | |
| Current assets |
458
|
380 | |
| Current liabilities |
386
|
310 | |
| Equity capital |
89
|
86 | |
| - share capital |
34
|
33 | |
| Employees (average) |
6
|
7
|
5 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
18.7%
|
21.7% | |
| Turnover per employee |
475
|
643 | |
| Profit as a percentage of turnover |
1.0%
|
9.4% | |
| Return on assets (ROA) |
8.6%
|
79.0% | |
| Current ratio |
118.7%
|
122.6% | |
| Return on equity (ROE) |
38.2%
|
352.3% | |
| Change turnover |
95
|
1,189 | |
| Change turnover % |
-21%
|
3%
|
59% |
| Chg. No. of employees |
-1
|
2
|
2 |
| Chg. No. of employees % |
-14%
|
40%
|
67% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.